Aug 25 2016 |
The Evolving Standard for Pleading Direct Patent Infringement |
Foley & Lardner LLP |
May 30 2018 |
The Expanded Scope of the Printed Matter Doctrine and Effect on “Mental Steps” |
Brinks Gilson & Lione |
Jan 19 2015 |
The Explicit Definition of a Claim Term Is Not Limiting Where It Excludes a Preferred Embodiment |
McDermott Will & Emery |
Sep 3 2019 |
The Faithless Servant Doctrine: Can an Employer Claw Back Compensation from an Employee Who Binge-Watches “Friends” During Work Hours? |
Epstein Becker & Green, P.C. |
Jul 24 2012 |
The Fate of the Music Industry is Jeopardized by Copyright Decision |
Dinsmore & Shohl LLP |
Sep 6 2012 |
The FDA Proposes New Rule on Unique Medical Device Identification and Marking Requirements |
Faegre Drinker |
Jul 21 2012 |
The FDA Safety and Innovation Act: Much More Than Just User Fees |
Barnes & Thornburg LLP |
Jun 16 2011 |
The Federal Circuit Affirms the Delaware District Court’s Summary Judgment of Invalidity for Failure to Disclose the Best Mode |
Morgan, Lewis & Bockius LLP |
Jan 24 2012 |
The Federal Circuit Agrees to Consider En Banc Whether Intervening Rights Can Apply To Independent Claims Not Amended During Reexamination |
Hunton Andrews Kurth |
Jul 1 2015 |
The Federal Circuit Alters the Means-Plus-Function Analysis |
Mintz |
Sep 30 2011 |
The Federal Circuit Applies Intervening Rights to Independent Claims Not Amended in Reexamination |
Hunton Andrews Kurth |
Jun 6 2019 |
The Federal Circuit Applies Issue Preclusion to IPRs (And Further Calls Into Question Long-Standing Precedent Against Issue Preclusion In ITC Actions) |
Vedder Price |
Jun 23 2020 |
The Federal Circuit Broadens Application of the Kessler Doctrine |
Mintz |
Dec 2 2016 |
The Federal Circuit Confirms That It Will Review PTAB’s CBM Determinations … To A Certain Extent |
Mintz |
Oct 9 2012 |
The Federal Circuit Continues to Make Inequitable Conduct More Difficult to Prove |
Sills Cummis & Gross P.C. |
Feb 19 2019 |
The Federal Circuit Continues to Narrow the Eligibility Standards for CBM Review of Patents Under the AIA |
Squire Patton Boggs (US) LLP |
Apr 6 2011 |
The Federal Circuit Court of Appeals Clarifies the Pleading Standard for False Patent Marking Claims Under 35 U.S.C. § 292 |
Michael Best & Friedrich LLP |
Oct 20 2015 |
The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? |
Squire Patton Boggs (US) LLP |
Oct 30 2014 |
The Federal Circuit Denies Interlocutory Appeal in Licensing Dispute |
McDermott Will & Emery |
Sep 5 2020 |
The Federal Circuit Expressly Declares that Juries Determine the Standard-Essentiality of Patent Claims |
Squire Patton Boggs (US) LLP |
Aug 12 2020 |
The Federal Circuit Finds a “Hooke” to Patent Ineligibility |
Squire Patton Boggs (US) LLP |
Nov 24 2012 |
The Federal Circuit Finds Declaratory Judgment Jurisdiction Exists Only with Immediacy and Reality |
McDermott Will & Emery |
Nov 15 2012 |
The Federal Circuit Finds that Section 282 Is Not a Safety Net to Protect Against Failure to Disclosure Relevant Information During Discovery |
McDermott Will & Emery |
Sep 2 2010 |
The Federal Circuit Holds That False Marking Plaintiff Has Standing to Sue in Stauffer v. Brooks Brothers |
Michael Best & Friedrich LLP |
Mar 3 2013 |
The Federal Circuit Is Not the Place for Side Bets (Re: Patent Infringement Litigation) |
McDermott Will & Emery |
Mar 11 2016 |
The Federal Circuit Newly Recognizes Patent-Agent Privilege |
Mintz |
Feb 5 2019 |
The Federal Circuit Provides New Direction on Patent Term Adjustment |
Squire Patton Boggs (US) LLP |
Apr 21 2021 |
The Federal Circuit Provides New Guidance for Patent Licensees Wishing to Challenge the Licensed Patent’s Validity |
Mintz |
Feb 22 2021 |
The Federal Circuit Raises the Enablement Bar for Antibody Patents |
Polsinelli PC |
Apr 22 2020 |
The Federal Circuit Reconsiders the Inherent Distinctiveness of Color Marks in In re Forney |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 1 2021 |
The Federal Circuit Rejects Infringement Arguments That Are Inconsistent with Prior Art Validity Arguments |
Finnegan |
Jul 30 2014 |
The Federal Circuit Reverse a Finding of Anticipation of the PTAB in Inter Partes Review |
McDermott Will & Emery |
Feb 26 2018 |
The Federal Circuit Reverses and Vacates Invalidity Determinations by the Board After Lack of Substantial Evidence Supported the Board’s Findings |
Hunton Andrews Kurth |
Feb 26 2018 |
The Federal Circuit Reverses and Vacates the District Court’s Dismissal Under Rule 12(b)(6), for not Considering Allegations of Fact That Could Preclude Dismissal |
Hunton Andrews Kurth |
May 31 2013 |
The Federal Circuit Reverses Summary Judgment that Reissue Patent Claims Were Not Obvious |
McDermott Will & Emery |
Jul 24 2018 |
The Federal Circuit Shuts the Door on Use of Tribal Immunity in IPRs |
Squire Patton Boggs (US) LLP |
Feb 20 2020 |
The Federal Circuit Takes a Mulligan and Reins in the Eastern District of Texas’s Assertion of Venue the Second Time Around |
Squire Patton Boggs (US) LLP |
Aug 28 2012 |
The Federal Circuit Will Decide if a Damages Trial or Decision on Willfulness Is Required Before a Judgment of Patent Infringement Can Be Appealed |
Sills Cummis & Gross P.C. |
Mar 31 2018 |
The Federal Circuit Will Decide Whether Sovereign Immunity Can be Used to Escape Patent Invalidation by the PTAB – If the Supreme Court Finds Inter Partes Review Constitutional |
Squire Patton Boggs (US) LLP |
Jun 4 2015 |
The Federal Circuit’s First Foray into the BPCIA: “A Pulitzer Prize for Complexity”? |
Mintz |
Feb 14 2020 |
The Federal Circuit’s Polaris Decision Provides Insights Into The Constitutionality Of Inter Partes Reviews |
Cadwalader, Wickersham & Taft LLP |
Oct 28 2011 |
The Federal Circuit’s Recent Reexamination Rulings |
Hunton Andrews Kurth |
Sep 22 2012 |
The Federal Circuit’s Recent “Safe Harbor” Ruling Could Impact Biosimilars Drug Development |
Faegre Drinker |
Jan 24 2017 |
The Federal Circuit’s Standing Requirement to Appeal Patent Office Decisions |
Proskauer Rose LLP |
Jul 21 2016 |
The Federal Defend Trade Secrets Act vs. The California Uniform Trade Secrets Act |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 19 2022 |
The Federal Trade Commission’s Five-Year Strategic Plan Unsurprisingly Includes a Focus on Noncompetes |
Epstein Becker & Green, P.C. |
Feb 4 2015 |
The Fight Against Counterfeit Products in Canada Just Got Easier |
Dickinson Wright PLLC |
Jan 28 2021 |
The Fight Continues: Being Prepared for Additional Litigation Following the Issuance of an International Trade Commission Exclusion |
Vedder Price |
Jan 24 2023 |
The Fight for Red: Fashion Statement or Protected Trademark? |
Stark & Stark |
Jul 8 2012 |
The Final Curtain Call? Not Quite Yet New Standard of Review for Willfulness |
McDermott Will & Emery |